Jietao Lin

552 total citations
39 papers, 380 citations indexed

About

Jietao Lin is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Jietao Lin has authored 39 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 14 papers in Pulmonary and Respiratory Medicine and 9 papers in Molecular Biology. Recurrent topics in Jietao Lin's work include Lung Cancer Treatments and Mutations (6 papers), Cancer survivorship and care (5 papers) and Lung Cancer Diagnosis and Treatment (4 papers). Jietao Lin is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), Cancer survivorship and care (5 papers) and Lung Cancer Diagnosis and Treatment (4 papers). Jietao Lin collaborates with scholars based in China, Australia and United Kingdom. Jietao Lin's co-authors include Jianhai Chen, Wenxiang Cheng, Peng Zhang, Xueling Bai, Yan Wang, Lizhu Lin, Bing Song, Guo‐Yuan Zhu, Zhanwang Xu and Donghao Gan and has published in prestigious journals such as PLoS ONE, Scientific Reports and Medicine.

In The Last Decade

Jietao Lin

35 papers receiving 375 citations

Peers

Jietao Lin

ONCOL

RHEUM

IMMUN

Chenghui Huang China

Xinchang Lu China

Cen Chang China

Bolin Chen China

Guohong Li China

Yiming Shi China

Lina Qi China

Tso‐Fu Wang Taiwan

Junli Ge China

Hao Zhong China

Chenghui Huang China

Jietao Lin

164 ×1.2

71 ×0.7

ONCOL

54 ×0.8

RHEUM

113 ×1.7

79 ×1.3

IMMUN

Citations per year, relative to Jietao Lin Jietao Lin (= 1×) peers Chenghui Huang

Countries citing papers authored by Jietao Lin

Since Specialization

Citations

This map shows the geographic impact of Jietao Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jietao Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jietao Lin more than expected).

Fields of papers citing papers by Jietao Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jietao Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jietao Lin. The network helps show where Jietao Lin may publish in the future.

Co-authorship network of co-authors of Jietao Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Jietao Lin. A scholar is included among the top collaborators of Jietao Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jietao Lin. Jietao Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Zhenqiu, Guohua Yu, Conghua Xie, et al.. (2025). Association between alkaline phosphatase levels and mortality in Chinese patients with colorectal cancer with liver metastases: a retrospective cohort study. Therapeutic Advances in Gastroenterology. 18. 1118494090–1118494090. 1 indexed citations

Luo, Xiaorong, Mo Yang, Jietao Lin, et al.. (2025). A novel model for predicting immunotherapy response and prognosis in NSCLC patients. Cancer Cell International. 25(1). 178–178. 1 indexed citations

Qi, Xiangjun, et al.. (2024). Vitamin E intake is inversely associated with NAFLD measured by liver ultrasound transient elastography. Scientific Reports. 14(1). 2592–2592. 16 indexed citations

Zhang, Zexin, et al.. (2024). Prediction and verification of benignancy and malignancy of pulmonary nodules based on inflammatory related biological markers. Heliyon. 10(15). e34585–e34585.

Chen, Zhiqiang, Lingling Sun, Xiangjun Qi, et al.. (2024). Yi-Fei-San-Jie Chinese medicine formula reverses immune escape by regulating deoxycholic acid metabolism to inhibit TGR5/STAT3/PD-L1 axis in lung cancer. Phytomedicine. 135. 156175–156175. 7 indexed citations

Yu, Ling, Jietao Lin, Hanhan Li, et al.. (2023). Case Report: Clinical benefit from multi-target tyrosine kinase inhibitor and PARP inhibitor in a patient with cancer of unknown primary with BRCA1 large genomic rearrangement. Frontiers in Pharmacology. 14. 997760–997760.

Lin, Jietao, et al.. (2023). Posterior reversible encephalopathy syndrome associated with use of anlotinib to treat squamous cell carcinoma of the cervix: case report and literature review. Frontiers in Pharmacology. 14. 1255785–1255785.

Yu, Zhanbo, et al.. (2023). Effect of Fu’s subcutaneous needling for cancer pain management: protocol for a pragmatic randomised controlled trial. BMJ Open. 13(4). e068232–e068232. 1 indexed citations

Fang, Chongkai, et al.. (2022). The Prognostic Value of Serum Apolipoprotein A-I Level and Neutrophil-to-Lymphocyte Ratio in Colorectal Cancer Liver Metastasis. Journal of Oncology. 2022. 1–13. 4 indexed citations

10.

Lin, Jietao, Ting Yang, Wen‐Ming Chen, et al.. (2022). Zhengyuan capsules for the treatment of chemotherapy-induced cancer-related fatigue in stage IIIB–IV unresectable NSCLC: study protocol for a randomized, multi-center, double-blind, placebo-controlled clinical trial. Journal of Thoracic Disease. 14(11). 4560–4570. 2 indexed citations

11.

Xiao, Zhiwei, Zhiqiang Chen, Rui Han, et al.. (2021). Comprehensive TCM treatments combined with chemotherapy for advanced non-small cell lung cancer. Medicine. 100(18). e25690–e25690. 18 indexed citations

12.

Deng, Li, Wei Guo, Shan Liu, et al.. (2021). Comprehensive analysis of an immune infiltrate-related competitive endogenous RNA network reveals potential prognostic biomarkers for non-small cell lung cancer. PLoS ONE. 16(12). e0260720–e0260720. 1 indexed citations

13.

Qi, Xiangjun, Guo-Ming Chen, Jing Li, et al.. (2021). Construction of a Novel Lung Adenocarcinoma Immune-Related lncRNA Pair Signature. International Journal of General Medicine. Volume 14. 4279–4289. 4 indexed citations

14.

Chen, Jianhai, Jinqing Chen, Wenxiang Cheng, et al.. (2021). Treatment of collagen-induced arthritis rat model by using Notch signalling inhibitor. Journal of Orthopaedic Translation. 28. 100–107. 24 indexed citations

15.

Fang, Chongkai, Jietao Lin, Tao Zhang, et al.. (2021). Metastatic Colorectal Cancer Patient With Microsatellite Stability and BRAFV600E Mutation Showed a Complete Metabolic Response to PD-1 Blockade and Bevacizumab: A Case Report. Frontiers in Oncology. 11. 652394–652394. 14 indexed citations

16.

Hu, Yiping, Tiantian Zhang, Wenxiang Cheng, et al.. (2020). Downregulation of Hypoxia-Inducible Factor-1α by RNA Interference Alleviates the Development of Collagen-Induced Arthritis in Rats. Molecular Therapy — Nucleic Acids. 19. 1330–1342. 33 indexed citations

17.

Lin, Jietao, Ling Yu, Hanrui Chen, et al.. (2020). A refractory case of CDK4-amplified spinal astrocytoma achieving complete response upon treatment with a Palbociclib-based regimen:a case report. BMC Cancer. 20(1). 630–630. 3 indexed citations

18.

Lin, Jietao, et al.. (2020). Lung abscess secondary to lung cancer with Eikenella corrodens and Streptococcus anginosus: a case report. BMC Infectious Diseases. 20(1). 351–351. 9 indexed citations

19.

Xiao, Zhiwei, et al.. (2020). Efficacy and safety of Jianpishengsui for chemotherapy-related fatigue in patients with non-small cell lung cancer: study protocol for a randomized placebo-controlled clinical trial. Trials. 21(1). 94–94. 4 indexed citations

20.

Lin, Jietao, et al.. (2018). Non-α-fetoprotein-producing adrenal hepatoid adenocarcinoma. Medicine. 97(39). e12336–e12336. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact